Literature DB >> 1138584

Prosthetic valve endocarditis.

W R Wilson, P M Jaumin, G K Danielson, E R Giuliani, I I Washington JA, J E Geraci.   

Abstract

From January 1963 until January 1974, 45 patients had prosthetic valve endocarditis. Symptoms of prosthetic valve endocarditis developed within 2 months after operation (early onset) in 16 patients (36%) and more than 2 months after operation (late onset) in 29 patients (64%). Overall mortality among the 45 patients was 56% (88% among those with early onset and 40% among those with late onset). Medical therapy alone was curative in 60% of the surviving patients. Combined medical and surgical therapy was curative in 40% of the survivors. The most frequent isolates in the early-onset group were Staphylococcus aureus (44%) and Gram-negative bacilli (38%); associated mortality was 86% and 83%, respectively. The most frequent isolates in the late-onset group were viridans streptococci (41%) and Gram-negative bacilli (31%); the mortality was 25% and 22% respectively. Suggestions are offered for operative antimicrobial prophylaxis and for medical and surgical treatment of prosthetic valve endocarditis. Prompt surgical replacement of an infected prosthesis is necessary when medical therapy fails.

Entities:  

Mesh:

Year:  1975        PMID: 1138584     DOI: 10.7326/0003-4819-82-6-751

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  27 in total

1.  Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin.

Authors:  Rabih O Darouiche; Vance G Fowler; Karim Adal; Marcia Kielhofner; David Mansouri; L Barth Reller
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae.

Authors:  M Venditti; V Gelfusa; A Tarasi; C Brandimarte; P Serra
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

3.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

4.  Erysipelothrix rhusiopathiae endocarditis.

Authors:  M Venditti; V Gelfusa; F Castelli; C Brandimarte; P Serra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

5.  Fifty cases of late prosthetic valve endocarditis: improvement in prognosis over a 15 year period.

Authors:  C Leport; J L Vilde; F Bricaire; A Cohen; B Pangon; C Gaudebout; P E Valere
Journal:  Br Heart J       Date:  1987-07

6.  Prosthetic valve endocarditis. A survey.

Authors:  M Ben Ismail; N Hannachi; F Abid; Z Kaabar; J F Rougé
Journal:  Br Heart J       Date:  1987-07

7.  Adherence of bacteria to heart valves in vitro.

Authors:  K Gould; C H Ramirez-Ronda; R K Holmes; J P Sanford
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Surgical progress: surgical management of infective endocarditis.

Authors:  S A Mills
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

Review 9.  Fungal endocarditis observed over an 8-year period and a review of the literature.

Authors:  Spinello Antinori; Laurenzia Ferraris; Giovanna Orlando; Loredana Tocalli; Davide Ricaboni; Mario Corbellino; Salvatore Sollima; Massimo Galli; Laura Milazzo
Journal:  Mycopathologia       Date:  2014-06-26       Impact factor: 2.574

10.  Gentamicin use and Pseudomonas and Serratia resistance: effect of a surgical prophylaxis regimen.

Authors:  N J Roberts; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.